Syrian Arab Republic

Reimbursed Care Access

Syria maintains a highly restrictive narcotics regime aligned with UN drug control conventions; most classic and novel psychedelics are illegal with no routine medical or reimbursed access. Ketamine is used as an anesthetic in clinical settings but procurement and supply are tightly controlled and often limited; there is no evidence of regulated, reimbursed access to esketamine (Spravato) or authorized psychedelic therapy programs outside of exceptional research. National law includes severe criminal penalties (including capital punishment in trafficking cases) under Syria’s narcotics legislation. [https://docstore.ohchr.org/SelfServices/FilesHandler.ashx?enc=EtAMNV9EIEXQiuR0w70D9pdEQBUCRK%2B22888%2B8e1fQppl8MXVPBz6uMPhO3ZkFLFBNedZghZUHcFE%2FLo%2B5QVZA%3D%3D|UN OHCHR report on Syrian narcotics law] [https://www.druglibrary.net/schaffer/GovPubs/ncsr/syria.htm|Country profile: Syria and UN drug conventions].